Contents I n tr o duction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 CA 125 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 T h e C A 1 2 5 Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 T h e Us e of the CA 125 Te st in M anag ing the Care of Women wi th Ovarian Cance r . . . . . . . . . . . . . . . . . . . . . . . 3 A Fi nal No te . . . . . . . . . . . . . . . . . . . . .
Bac k C ov er
The Foundation for Women’s Cancer, formerly the Gynecologic Cancer Foundation, was established by the Society of Gynecologic Oncology in 1991 to increase funding for research and training, and to develop educational and awareness programs for women. These programs focus on the prevention, early detection and optimal treatment of gynecologic cancers. As a 501(c)(3) not-for-profit charitable organization, the Foundation for Women’s Cancer raises funds to support these programs from both public and private sources.